CPH News and Events

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast cancer after two years than women who undergo surgery to remove them.

The Center for Precision Health has welcomed Opeyemi Olabisi, MD, PhD, associate professor of medicine.

Olabisi's research focuses on APOL1 variants that contribute to the progression of kidney disease. His ultimate goal is to translate his findings into improved diagnostic and treatment approaches for chronic kidney disease.

As a clinician, Olabisi cares for individuals with various degrees of kidney disease. He is passionate about raising awareness about kidney disease and introduce remedies that could slow the progression of kidney disease.

Currently, many patients receive inconclusive results from genetic testing, leaving them without a clear diagnosis or a path forward for treatment, but a new model developed by researchers at Duke University could help increase the number of patients receiving positive test results, providing them with valuable information that could guide treatment decisions. Results were published in Circulation: Genomic and Precision Medicine.

The Duke Center for Precision Health and Precision Genomics Collaboratory have awarded five pilot grants to advance genomic science at Duke by leveraging and enhancing the OneDukeGen study infrastructure. This opportunity was open to all Duke University School of Medicine faculty.

With a career that started at NASA and ended with engineering software for genomics research, Duke patient Sharon is not shy about her passion for science and the value of scientific research. It should come as no surprise then that when, during an appointment at the Duke Cardiac Catheterization Lab, she was asked to join the OneDukeGen study, she was all in.

Driven by a deep desire to heal, Mihai V. Podgoreanu, MD, searches for solutions as he seeks to transform perioperative medicine and critical care into a system that is not just reactive, but predictive, preventive, and personalized.

Duke University, in collaboration with the Veterans Health Administration (VA), has received one of six awards from a new $27 million initiative from the National Institutes of Health to establish a genomics-enabled Learning Health System (G-LHS) network

A first-of-its-kind study documents Durham neighborhoods with higher levels of structural racism also have higher rates of chronic disease. Duke researchers are expanding their work to help others conduct similar studies in their own cities, and to use that data to inform policy efforts to intervene where it’s needed most.

In an editorial published in JAMA Cardiology, CPH faculty leader Senthil Selvaraj, MD, and others compare two approaches to improve detection of an underdiagnosed, undertreated systemic disease called transthyretin amyloidosis.

More than one in five people in the United States live with a mental illness, according to the National Institutes of Health. With several available drugs on the market for some of these conditions, like depression, it can be challenging to know what prescription will work best for individual patients. Oftentimes, though, these drugs take several weeks to feel the full effect, leaving patients in a state of limbo as they wait to see if their medication will work and provide them with relief or if they will need to try something else.